Qube Research & Technologies (QRT)’s Regencell Bioscience RGC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-494	Closed	-$44	–	3971
2024 Q2	$44	Hold	494	–	–	﹤0.01%	3512
2024 Q1	$64	Hold	494	–	–	﹤0.01%	4203
2023 Q4	$122	Hold	494	–	–	﹤0.01%	4015
2023 Q3	$185	Buy	+494	New	+$206	﹤0.01%	3735
2022 Q2	–	Sell	-658,502	Closed	-$371K	–	3029
2022 Q1	$371K	Buy	+658,502	New	+$565K	﹤0.01%	1675

Other funds holding RGC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RGC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Regencell Bioscience (RGC) in Q3 2024, closing a stake of 494 shares — an estimated $44 sold.

Qube Research & Technologies (QRT) first reported a position in RGC in Q1 2022 and held it in 5 quarters. The position peaked at $371K in Q1 2022. 2 funds tracked by Wall St. Rank hold RGC as of Q3 2024.

Qube Research & Technologies (QRT) reported no remaining Regencell Bioscience position as of Q3 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 494 Regencell Bioscience shares in Q3 2024, an estimated $44.
Qube Research & Technologies (QRT) first reported a position in Regencell Bioscience in Q1 2022 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s Regencell Bioscience position peaked at $371K in Q1 2022.
2 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.